NCT04367857 ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
| NCT ID | NCT04367857 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Covid-19 |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2020-04-18 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2020-04-18 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus). The investigators will describe health worker mental and emotional well-being and their coping strategies in their institutional settings. Lastly, the investigators will describe how knowing serostatus can affect individuals' mental and emotional well-being and how to cope in the midst of the COVID-19 response. This will help to how to better test and help healthcare workers in the COVID-19 pandemic and prepare for possible future outbreaks.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * NewYork-Presbyterian (NYP) healthcare personnel employee or affiliate * Understands and reads English Exclusion Criteria: * Younger than 18 years of age * Mentally and/or physically unable to complete study requirements
Contact & Investigator
Magdalena Sobieszczyk, MD, MPH
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT04367857 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Covid-19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04367857 currently recruiting?
Yes, NCT04367857 is actively recruiting participants. Contact the research team at bg2168@cumc.columbia.edu for enrollment information.
Where is the NCT04367857 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04367857 clinical trial?
NCT04367857 is sponsored by Columbia University. The principal investigator is Magdalena Sobieszczyk, MD, MPH at Columbia University. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.